Pharmacokinetics and metabolism of oral midazolam in preterm infants.
about
Developmental pharmacokinetics in pediatric populationsClinical pharmacology of midazolam in neonates and children: effect of disease-a reviewOntogeny of midazolam glucuronidation in preterm infants.Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.Pain management in newborns.Paediatric pharmacokinetics: key considerations.Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infantsAnesthesia and analgesia in the NICU.Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma.Drugs of choice for sedation and analgesia in the neonatal ICU.Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and AdultsOptimizing pediatric dosing: a developmental pharmacologic approach.Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.Ontogeny of oral drug absorption processes in children.Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.Pediatric drug development: formulation considerations.Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.Challenges Associated with Route of Administration in Neonatal Drug Delivery.Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status.Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug.A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.Response to: “Prediction of Voriconazole Non-Linear Pharmacokinetics Using a Paediatric Physiologically Based Pharmacokinetic Modelling Approach”
P2860
Q27002933-37AAD3BD-6F02-4817-8005-CCC0F9E3AC20Q27006333-F0082DE0-5EBB-4B0D-9C8B-4EE4B959899FQ33587843-7A643736-FE54-4615-8DCB-6B5B6913F990Q33942993-50DE36EA-A38F-440A-9594-C3D15727EB07Q34625140-11B40FC5-13C6-411A-87DD-317E34EDBDAAQ35135940-D4ED29D6-F48B-4071-9EB7-644C949814D8Q35867330-E8934BDF-5F3F-4D5D-9CFA-CE3E97534334Q36730497-9DFC8824-7398-4A60-9A07-49E42C38AE1EQ37067431-5B79A163-6B1E-4C44-A8A6-50671ABEE13DQ37144585-0EBECA1D-BE5F-42A6-8AE7-6618D2122359Q37378093-3AEF3957-6EA2-4654-BA37-DF4B005ABC1DQ37498862-9D69875D-B807-42F4-BF3B-0D8ECB47BA3BQ37872786-5CA22DFF-BEF6-49B4-8A29-D2DECCFA3933Q38017723-AA3AFE18-9AD7-486B-B067-E4C4754F2574Q38086777-4062785D-EE72-49F0-91B1-25658E4F009FQ38183868-0B960AEE-C995-4356-BEDB-B60FA9BBC748Q38187348-72A19FFF-977D-48EE-AF33-4B791DA59CB7Q38561363-4CFFBA01-B98D-4BEE-80A8-93BF25C22421Q39038877-DEAF618B-4820-4214-A36E-2DFEA3E1F164Q40772216-8750A9B1-5D24-47F9-93D1-3C34FBEEF264Q47781069-37DFD428-D53F-408A-BE3E-34DE120BD7DAQ48151911-0724460F-1737-4FCF-9E6B-A726A40B6D9EQ48333229-68273B52-DCDD-4143-A18D-817054AAB2AFQ55454780-1269AEC0-DBE5-49C7-9BED-A26B0BFB2524Q57730438-5D7B4B11-3966-4D49-8E74-554655F80548
P2860
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@ast
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@en
type
label
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@ast
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@en
prefLabel
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@ast
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@en
P2093
P2860
P1476
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
@en
P2093
G L Kearns
J N van den Anker
S M Abdel-Rahman
S N de Wildt
P2860
P304
P356
10.1046/J.1365-2125.2002.01223.X
P407
P577
2002-04-01T00:00:00Z